Shares of Hinge Health, Inc. (HNGE) are soaring 22.66% in their New York Stock Exchange debut on Thursday, showcasing strong investor appetite for the digital health startup. The impressive first-day performance comes after the company successfully priced its initial public offering (IPO) at $32 per share, the top end of its marketed range, raising $437 million.

Hinge Health, which specializes in digital solutions for joint and muscle pain management, offered approximately 13.7 million shares to the public. The strong demand for the IPO and the subsequent stock surge reflect investor confidence in the company's business model and growth prospects in the expanding digital health sector.

The company's recent financial performance likely contributed to investor enthusiasm. In the first quarter of 2025, Hinge Health reported a net income of $17.14 million on revenue of $123.83 million, marking a significant improvement from the loss it incurred in the same period last year. With a client list exceeding 2,250 companies, including high-profile names like Morgan Stanley, Target, and GM, Hinge Health has demonstrated its ability to attract and retain major customers.

The successful debut of Hinge Health, along with other recent tech IPOs, signals a potential resurgence in the IPO market. This positive reception may encourage other companies in the pipeline to move forward with their public offerings, potentially leading to increased activity in the new issues market in the coming months.